113 related articles for article (PubMed ID: 15792789)
1. Differential respiratory effects of [Dmt1]DALDA and morphine in mice.
Shimoyama M; Kuwaki T; Nakamura A; Fukuda Y; Shimoyama N; Schiller PW; Szeto HH
Eur J Pharmacol; 2005 Mar; 511(2-3):199-206. PubMed ID: 15792789
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.
Shimoyama M; Shimoyama N; Zhao GM; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2001 Apr; 297(1):364-71. PubMed ID: 11259564
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.
Kokubu S; Eddinger KA; Nguyen TM; Huerta-Esquivel LL; Yamaguchi S; Schiller PW; Yaksh TL
Scand J Pain; 2019 Jan; 19(1):193-206. PubMed ID: 30367811
[TBL] [Abstract][Full Text] [Related]
4. Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
Shimoyama M; Szeto HH; Schiller PW; Tagaito Y; Tokairin H; Eun Cm; Shimoyama N
Pharmacology; 2009; 83(1):33-7. PubMed ID: 18987489
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivities of mouse strains to morphine and [Dmt1]DALDA analgesia.
Neilan CL; King MA; Rossi G; Ansonoff M; Pintar JE; Schiller PW; Pasternak GW
Brain Res; 2003 Jun; 974(1-2):254-7. PubMed ID: 12742645
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.
Neilan CL; Nguyen TM; Schiller PW; Pasternak GW
Eur J Pharmacol; 2001 May; 419(1):15-23. PubMed ID: 11348625
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
8. Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.
Ben Y; Smith AP; Schiller PW; Lee NM
Br J Pharmacol; 2004 Dec; 143(8):987-93. PubMed ID: 15557286
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
10. Effects of intrathecal morphine on the ventilatory response to hypoxia.
Bailey PL; Lu JK; Pace NL; Orr JA; White JL; Hamber EA; Slawson MH; Crouch DJ; Rollins DE
N Engl J Med; 2000 Oct; 343(17):1228-34. PubMed ID: 11071674
[TBL] [Abstract][Full Text] [Related]
11. Reduced suppression of CO2-induced ventilatory stimulation by endomorphins relative to morphine.
Czapla MA; Zadina JE
Brain Res; 2005 Oct; 1059(2):159-66. PubMed ID: 16223471
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Analgesic Actions of the Chronic Intrathecal Infusion of H-Dmt-D-Arg-Phe-Lys-NH2 in Rat.
Kokubu S; Eddinger KA; Yamaguchi S; Huerta-Esquivel LL; Schiller PW; Yaksh TL
Neuromodulation; 2019 Oct; 22(7):781-789. PubMed ID: 30794333
[TBL] [Abstract][Full Text] [Related]
13. Respiratory effects of morphine in awake unrestrained rats.
van den Hoogen RH; Colpaert FC
J Pharmacol Exp Ther; 1986 Apr; 237(1):252-9. PubMed ID: 3083095
[TBL] [Abstract][Full Text] [Related]
14. Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain.
Shimoyama M; Schiller PW; Shimoyama N; Toyama S; Szeto HH
Chem Biol Drug Des; 2012 Nov; 80(5):771-4. PubMed ID: 22834682
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the analgesic and respiratory effects of N-allylnorcodeine (nalodeine), nalorphine, codeine and morphine.
Rundlett Beyer J; Elliott HW
J Pharmacol Exp Ther; 1976 Aug; 198(2):330-9. PubMed ID: 948029
[TBL] [Abstract][Full Text] [Related]
16. The bifunctional μ opioid agonist/antioxidant [Dmt(1)]DALDA is a superior analgesic in an animal model of complex regional pain syndrome-type i.
Schiller PW; Nguyen TM; Saray A; Poon AW; Laferrière A; Coderre TJ
ACS Chem Neurosci; 2015 Nov; 6(11):1789-93. PubMed ID: 26352668
[TBL] [Abstract][Full Text] [Related]
17. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
Negri L; Lattanzi R; Tabacco F; Melchiorri P
Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacokinetics of selective mu-opioid peptide agonists.
Szeto HH; Lovelace JL; Fridland G; Soong Y; Fasolo J; Wu D; Desiderio DM; Schiller PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):57-61. PubMed ID: 11408525
[TBL] [Abstract][Full Text] [Related]
19. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
